• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.

作者信息

Kuo Chang-Fu, Grainge Matthew J, Mallen Christian, Zhang Weiya, Doherty Michael

机构信息

Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Division of Epidemiology and Public Health, University of Nottingham, Nottingham, England.

出版信息

JAMA. 2014;312(24):2684-6. doi: 10.1001/jama.2014.14484.

DOI:10.1001/jama.2014.14484
PMID:25536262
Abstract
摘要

相似文献

1
Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.英格兰初发痛风患者降尿酸治疗的适用资格与处方情况
JAMA. 2014;312(24):2684-6. doi: 10.1001/jama.2014.14484.
2
A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.一个痛苦的世界：痛风患者未能实现治疗目标需要一种范式转变。
Postgrad Med. 2016 Jan;128(1):34-40. doi: 10.1080/00325481.2016.1113840. Epub 2015 Nov 17.
3
Management of gout in the real world: current practice versus guideline recommendations.现实世界中痛风的管理：当前实践与指南建议
Postgrad Med. 2016 Jan;128(1):106-14. doi: 10.1080/00325481.2016.1114878. Epub 2015 Nov 23.
4
Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.痛风的治疗质量：一项针对真实世界痛风患者降尿酸治疗达标情况的临床审核。
Rheumatol Int. 2017 Sep;37(9):1435-1440. doi: 10.1007/s00296-017-3777-3. Epub 2017 Jul 26.
5
Knowledge of and Stated Adherence to the 2020 American College of Rheumatology Guideline for Gout Management: Results of a Survey of US Rheumatologists.对2020年美国风湿病学会痛风管理指南的了解及声明的遵循情况：美国风湿病学家调查结果
J Rheumatol. 2025 Jan 1;52(1):77-86. doi: 10.3899/jrheum.2023-0981.
6
Inpatient management of gout in a New Zealand hospital: a retrospective audit.新西兰一家医院痛风患者的住院管理：一项回顾性审计。
Int J Rheum Dis. 2016 Feb;19(2):205-10. doi: 10.1111/1756-185X.12578. Epub 2015 Apr 15.
7
Physician adherence to ACR gout treatment guidelines: perception versus practice.医生对美国风湿病学会痛风治疗指南的遵循情况：认知与实践
Postgrad Med. 2014 May;126(3):257-67. doi: 10.3810/pgm.2014.05.2774.
8
Evaluating appropriate use of prophylactic colchicine for gout flare prevention.评估预防性使用秋水仙碱预防痛风发作的合理应用情况。
Arthritis Care Res (Hoboken). 2014 Aug;66(8):1258-62. doi: 10.1002/acr.22275.
9
Lessons and pitfalls from the 2020 Gout Clinical Practice Guideline presented in Atlanta at the ACR 2019.2019 年美国风湿病学会年会上在亚特兰大发布的 2020 年痛风临床实践指南：经验教训与陷阱。
Clin Rheumatol. 2020 Jun;39(6):2011-2016. doi: 10.1007/s10067-020-05070-y. Epub 2020 Apr 21.
10
Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy.痛风患者的静脉血栓栓塞症及其与住院、疾病持续时间和降尿酸治疗的关系。
CMAJ. 2019 Jun 3;191(22):E597-E603. doi: 10.1503/cmaj.180717.

引用本文的文献

1
Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study.痛风患者5年后不坚持降尿酸治疗与不良预后相关：来自NOR-Gout研究的结果
Rheumatology (Oxford). 2025 Apr 1;64(4):1799-1806. doi: 10.1093/rheumatology/keae514.
2
Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study.痛风患者工作生产力的病程和预测因素 - 来自 NOR-Gout 纵向 2 年达标治疗研究的结果。
Rheumatology (Oxford). 2023 Dec 1;62(12):3886-3892. doi: 10.1093/rheumatology/kead124.
3
A glance into the future of gout.
痛风的未来展望
Ther Adv Musculoskelet Dis. 2022 Jul 28;14:1759720X221114098. doi: 10.1177/1759720X221114098. eCollection 2022.
4
Incident Gout: Risk of Death and Cause-Specific Mortality in Western Sweden: A Prospective, Controlled Inception Cohort Study.新发痛风：瑞典西部的死亡风险及特定病因死亡率：一项前瞻性、对照性起始队列研究。
Front Med (Lausanne). 2022 Feb 24;9:802856. doi: 10.3389/fmed.2022.802856. eCollection 2022.
5
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target.真实世界观察性达标与强化治疗 NOR-Gout 研究的 12 个月结果：尿酸达标水平的实现情况及其达标预测因素。
RMD Open. 2021 Mar;7(1). doi: 10.1136/rmdopen-2021-001628.
6
Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review.改善痛风患者降尿酸治疗接受率的干预措施：一项系统评价
BJGP Open. 2020 Aug 25;4(3). doi: 10.3399/bjgpopen20X101051. Print 2020 Aug.
7
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.全球痛风流行病学：患病率、发病率、治疗模式和危险因素。
Nat Rev Rheumatol. 2020 Jul;16(7):380-390. doi: 10.1038/s41584-020-0441-1. Epub 2020 Jun 15.
8
Variation in methods, results and reporting in electronic health record-based studies evaluating routine care in gout: A systematic review.基于电子健康记录的痛风常规治疗评估研究中方法、结果和报告的差异：系统评价。
PLoS One. 2019 Oct 24;14(10):e0224272. doi: 10.1371/journal.pone.0224272. eCollection 2019.
9
Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.英国医疗系统中痛风与晚期慢性肾病风险：一项全国队列研究
BMJ Open. 2019 Aug 28;9(8):e031550. doi: 10.1136/bmjopen-2019-031550.
10
Patterns of health care utilization of gout patients in Hawai'i-high rates of emergency department utilization as compared to rheumatoid arthritis.夏威夷痛风患者的医疗保健利用模式-与类风湿性关节炎相比，急诊室利用率较高。
PLoS One. 2019 Aug 15;14(8):e0220978. doi: 10.1371/journal.pone.0220978. eCollection 2019.